CRIS Current Research Information System

MONTI, BARBARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.514
EU - Europa 4.689
AS - Asia 4.330
AF - Africa 412
SA - Sud America 311
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.277
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.410
IT - Italia 1.823
SG - Singapore 1.408
CN - Cina 1.377
GB - Regno Unito 693
VN - Vietnam 460
DE - Germania 451
SE - Svezia 382
HK - Hong Kong 332
IN - India 258
BR - Brasile 226
RU - Federazione Russa 194
NL - Olanda 187
KR - Corea 182
FR - Francia 170
CI - Costa d'Avorio 159
IE - Irlanda 127
TG - Togo 110
UA - Ucraina 104
FI - Finlandia 81
JP - Giappone 69
ZA - Sudafrica 68
CA - Canada 59
ES - Italia 58
AT - Austria 57
BG - Bulgaria 53
CH - Svizzera 49
TW - Taiwan 48
EE - Estonia 40
BE - Belgio 38
AR - Argentina 34
PL - Polonia 34
ID - Indonesia 33
JO - Giordania 33
MX - Messico 33
NG - Nigeria 32
PT - Portogallo 32
IR - Iran 31
HR - Croazia 29
SC - Seychelles 28
BD - Bangladesh 23
GR - Grecia 22
EC - Ecuador 19
TR - Turchia 19
RO - Romania 18
AU - Australia 16
CL - Cile 9
NO - Norvegia 9
CZ - Repubblica Ceca 8
PK - Pakistan 8
PY - Paraguay 8
TH - Thailandia 7
LI - Liechtenstein 6
LT - Lituania 6
CO - Colombia 5
IL - Israele 5
LB - Libano 5
CU - Cuba 4
IQ - Iraq 4
NP - Nepal 4
NZ - Nuova Zelanda 4
SA - Arabia Saudita 4
SN - Senegal 4
UY - Uruguay 4
UZ - Uzbekistan 4
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
MY - Malesia 3
PH - Filippine 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
LV - Lettonia 2
MK - Macedonia 2
PE - Perù 2
RS - Serbia 2
SI - Slovenia 2
TZ - Tanzania 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BW - Botswana 1
CR - Costa Rica 1
EG - Egitto 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
JM - Giamaica 1
KE - Kenya 1
KH - Cambogia 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MZ - Mozambico 1
PA - Panama 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 15.274
Salva come PNG Salva come JPEG
Città #
Singapore 966
Ashburn 660
Bologna 660
Southend 550
Chandler 490
Fairfield 462
Hefei 370
Hong Kong 323
Dallas 294
Ann Arbor 253
Woodbridge 240
Santa Clara 226
Houston 196
Cambridge 194
Wilmington 192
Seattle 180
Beijing 170
Seoul 166
Abidjan 159
Princeton 147
Dublin 126
Boardman 118
Lomé 110
Ho Chi Minh City 106
Turin 92
Milan 91
New York 77
Los Angeles 73
Hanoi 71
Redmond 70
Helsinki 66
Dong Ket 63
Berlin 62
Nanjing 58
Tokyo 54
Westminster 53
Sofia 47
Jacksonville 45
Padova 45
Vienna 44
Bengaluru 42
Buffalo 39
Redondo Beach 39
Council Bluffs 37
Forlì 37
Saint Petersburg 35
Brussels 34
Munich 34
São Paulo 34
Amman 33
Chicago 32
Rome 32
Bern 31
Frankfurt am Main 31
London 30
San Diego 30
Abeokuta 28
Changsha 28
Guangzhou 28
Falls Church 26
Jinan 26
Medford 26
Brooklyn 25
Hyderabad 24
Reggio Emilia 23
Tianjin 23
Bari 22
Des Moines 22
Falkenstein 22
Warsaw 21
Jakarta 20
Shanghai 20
Phoenix 19
Washington 19
Dearborn 18
Boston 17
Kaohsiung 17
Nuremberg 17
Redwood City 17
Rimini 17
Yubileyny 17
Amsterdam 16
Barcelona 16
Toronto 16
Montreal 15
Nanchang 15
Shenyang 15
Wayne 15
Mülheim 14
Ravenna 14
San Jose 14
Biên Hòa 13
Brisbane 13
Mexico City 13
Modena 13
Verona 13
Bremen 12
Jiaxing 12
Lauterbourg 12
New Delhi 12
Totale 9.724
Salva come PNG Salva come JPEG
Nome #
3,4-Dihydro-1,3,5-triazin-2(1H)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer's Disease 379
A Focused Library of Psychotropic Analogues with Neuroprotective and Neuroregenerative Potential 362
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease. 297
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatment 288
Characterization of DNA methylation as a function of biological complexity via dinucleotide inter-distances 283
Changing paradigm to target microglia in neurodegenerative diseases: from anti-inflammatory strategy to active immunomodulation. 250
Correction: Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent to Combat Alzheimer's Disease (ACS Medicinal Chemistry Letters (2019) 10: 4 (469−474) DOI: 10.1021/acsmedchemlett.8b00507) 241
Dysregulation of long non-coding RNAs in neuroinflammation: characterization of LINC00520 and its possible role in Parkinson's disease 240
Deficiency of Mitochondrial Aspartate-Glutamate Carrier 1 Leads to Oligodendrocyte Precursor Cell Proliferation Defects Both In Vitro and In Vivo 236
Tau-Centric Multitarget Approach for Alzheimer's Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors 225
Histone Acetylation Defects in Brain Precursor Cells: A Potential Pathogenic Mechanism Causing Proliferation and Differentiation Dysfunctions in Mitochondrial Aspartate-Glutamate Carrier Isoform 1 Deficiency 218
Dual-Acting Cholinesterase-Human Cannabinoid Receptor 2 Ligands Show Pronounced Neuroprotection in Vitro and Overadditive and Disease-Modifying Neuroprotective Effects in Vivo 216
Epigenetics and Communication Mechanisms in Microglia Activation with a View on Technological Approaches 215
Discovery of Dual Aβ/Tau Inhibitors and Evaluation of Their Therapeutic Effect on a Drosophila Model of Alzheimer's Disease 213
Melatonin- And Ferulic Acid-Based HDAC6 Selective Inhibitors Exhibit Pronounced Immunomodulatory Effects in Vitro and Neuroprotective Effects in a Pharmacological Alzheimer's Disease Mouse Model 210
N-1,2,3-triazole-isatin derivatives for cholinesterase and β-amyloid aggregation inhibition: A comprehensive bioassay study 204
Integrating a quinone substructure into histone deacetylase inhibitors to cope with Alzheimer's disease and cancer 203
Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose 203
Metabolic supplementations and epigenetic alterations in in vitro AGC1 deficiency models 200
Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. 198
Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease 198
Novel Sustainable-by-Design HDAC Inhibitors for the Treatment of Alzheimer's Disease 195
Chronic dietary administration of valproic acid protects neurons of the rat nucleus basalis magnocellularis from ibotenic acid neurotoxicity 194
In vitro and in vivo toxicity of type 2 ribosome-inactivating proteins lanceolin and stenodactylin on glial and neuronal cells. 194
Neuronal Regulation of Neuroprotective Microglial Apolipoprotein E Secretion in Rat In Vitro Models of Brain Pathophysiology. 193
Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection 193
Chronic treatment with hormonal contraceptives alters hippocampal BDNF and histone H3 post-translational modifications but not learning and memory in female rats 187
α-linolenic acid-valproic acid conjugates: Toward single-molecule polypharmacology for multiple sclerosis 184
Transcriptional and metabolic effects of aspartate-glutamate carrier isoform 1 (AGC1) downregulation in mouse oligodendrocyte precursor cells (OPCs) 176
Long INterspersed nuclear Elements (LINEs) in brain and non-brain tissues of the rat 176
Cell-Based Assays to Assess Neuroprotective Activity 175
Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death. 172
Multitarget Drug Design Strategy: Quinone–Tacrine Hybrids Designed To Block Amyloid-β Aggregation and To Exert Anticholinesterase and Antioxidant Effects 170
Dietary Protein Source Influences Brain Inflammation and Memory in a Male Senescence-Accelerated Mouse Model of Dementia 170
Neuroprotection of microglial conditioned medium on 6-hydroxydopamine-induced neuronal death: role of transforming growth factor beta2 169
Valproic acid neuroprotection in 6-OHDAlesioned rat, a model for parkinson's disease 168
Evidence for purine nucleoside phosphorylase (PNP) release from RAT C6 glioma cells. 167
Targeted quantitative metabolic profiling of brain-derived cell cultures by semi-automated MEPS and LC-MS/MS 163
CRY1 variations impacts on the depressive relapse rate in a sample of bipolar patients 163
Tampering with microglia-mediated neuroinflammation by means of DNA nanostructures 163
Characterization of the lncRNA LINC00520 in the developing and adult central nervous system and its correlation to neurodegenerative processes 160
Dysregulation of memory-related proteins in the hippocampus of aged rats and their relation with cognitive impairment. 160
The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms. 159
Phenothiazine-Tacrine Heterodimers: Pursuing Multitarget Directed Approach in Alzheimer's Disease 159
Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR 158
Histone post-translational modifications in Huntington's and Parkinson's diseases. 157
Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha synuclein 156
Progetto Telethon GGP11139 “Mitochondrial Aspartate/Glutamate Carrier 1 Deficiency: Pathogenetic Mechanisms and Mutational Analysis” (2011-2014) 155
New tacrine dimers with antioxidant linkers as dual drugs: Anti-Alzheimer's and antiproliferative agents 154
Chronic valproic acid administration impairs contextual memory and dysregulates hippocampal GSK-3β in rats. 153
Genetic variations within metalloproteinases impact on the prophylaxis of depressive phases in bipolar patients. 152
Subchronic rolipram delivery activates hippocampal CREB and Arc. enhances retention and slows down extinction of conditioned fear. 149
Up-regulation of LINC00520 in in vitro models of Parkinson's disease: searching for a physiological role and dysregulation in neurodegeneration 148
Alterations of markers related to synaptic function in aging rat brain, in normal conditions or under conditions of long-term dietary manipulation 146
Riluzole-Rasagiline Hybrids: Toward the Development of Multi-Target-Directed Ligands for Amyotrophic Lateral Sclerosis 144
Unveiling the role of exosomal miRNAs in the spreading of neuroinflammation 143
Disease-related regressive alterations of forebrain cholinergic system in SOD1 mutant transgenic mice 142
Memory-enhancing drugs: a molecular perspective 141
TDP-43 Modulation by Tau-Tubulin Kinase 1 Inhibitors: A New Avenue for Future Amyotrophic Lateral Sclerosis Therapy 141
Neuronal-glial Interactions Define the Role of Nitric Oxide in Neural Functional Processes 140
From combinations to single-molecule polypharmacology—cromolyn-ibuprofen conjugates for alzheimer’s disease 135
Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis 134
The bivalent ligand approach as a tool for improving the in vitro anti-Alzheimer multitarget profile of dimebon 133
Targeting Lewy body dementia with neflamapimod-rasagiline hybrids 129
Microglia and neuroprotection: from in vitro studies to therapeutic applications. 127
Updating the dual role of brain nitric oxide in neurodegeneration/neuroprotection: understanding molecular mechanisms to devise drug approaches. 125
Microstructured soft devices for the growth and analysis of populations of homogenous multicellular tumor spheroids 125
Correction to: Selection of suitable reference genes for gene expression studies in HMC3 cell line by quantitative real-time RT-PCR (Scientific Reports, (2024), 14, 1, (2431), 10.1038/s41598-024-52415-7) 122
Tacrine-O-protected phenolics heterodimers as multitarget-directed ligands against Alzheimer's disease: Selective subnanomolar BuChE inhibitors 122
Ketone bodies resume mitochondrial respiration in neuronal progenitors from iPSCs of patients with AGC1 deficiency 120
New models of Parkinson’s like neuroinflammation in human microglia clone 3: Activation profiles induced by INF-γ plus high glucose and mitochondrial inhibitors 119
Investigating the role of lncRNAs in CNS pathophysiology: LINC00520 as a potential biomarker for Parkinson’s disease in human in vitro models 118
Dual-Acting Small Molecules: Subtype-Selective Cannabinoid Receptor 2 Agonist/Butyrylcholinesterase Inhibitor Hybrids Show Neuroprotection in an Alzheimer's Disease Mouse Model. 116
Copper-Zinc Superoxide Dismutase (SOD1) Is Released by Microglial Cells and Confers Neuroprotection against 6-OHDA Neurotoxicity. 115
Release of soluble and vesicular purine nucleoside phosphorylase from rat astrocytes and microglia induced by pro-inflammatory stimulation with extracellular ATP via P2X7 receptors. 115
Activation of human microglia clone 3 (HMC3) in response to stress conditions: are long non-coding RNAs involved? 114
Telethon GGP19067-2019 - "Alla ricerca di nuovi bersagli terapeutici per contrastare l’ipomielinizzazione nell’AGC1 deficiency: uno studio multidisciplinare sui precursori delle cellule cerebrali". 112
Histone post-translational modifications to target memory-related diseases. 109
Selective Pseudo-irreversible Butyrylcholinesterase Inhibitors Transferring Antioxidant Moieties to the Enzyme Show Pronounced Neuroprotective Efficacy in Vitro and in Vivo in an Alzheimer's Disease Mouse Model 108
Down-regulation of the mitochondrial aspartate-glutamate carrier isoform 1 AGC1 inhibits proliferation and N-acetylaspartate synthesis in Neuro2A cells. 106
null 98
Epigenetic mechanisms underlying opiate dependence. 94
Neuroprotezione e meccanismi molecolari delle interazioni tra microglia e neuroni: studio cellulare, funzionale e comportamentale. 93
null 91
null 85
null 85
null 85
Bio-organic self-assembled DNA nanostructures and their use in the mitigation of the activation of microglia in neuroinflammation 84
Science on both sides of Atlantic (I,II and III) 83
Tacrine-resveratrol fused hybrids as multi-target-directed ligands against Alzheimer's disease 81
null 79
Coumarin-azasugar-benzyl conjugates as non-neurotoxic dual inhibitors of butyrylcholinesterase and cancer cell growth 77
null 75
Guest editor della special Issue "Microglia in neurodegeneration" nella sezione "Molecular Biology" della rivista Biomolecules 75
Unveiling the antitumor mechanism of 7α-acetoxy-6β-hydroxyroyleanone from Plectranthus hadiensis in glioblastoma 70
A nutritional approach to tackle Alzheimer's disease: a key role for immunomodulation 67
Zinc supplementation in rats impairs hippocampal-dependent memory consolidation and dampens post-traumatic recollection of stressful event. 67
The mitochondrial aspartate/glutamate carrier does not transport GABA 56
p57kip2 nuclear export as a marker of oligodendrocytes differentiation: Towards an innovative phenotyping screening for the identification of myelin repair drugs 54
Multitarget drug discovery for Alzheimer's disease: triazinones as BACE-1 and GSK-3β inhibitors. 52
Totale 15.423
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.417
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.417
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021835 0 0 0 0 0 135 54 85 151 84 101 225
2021/20221.714 131 45 89 74 152 103 87 183 131 159 278 282
2022/20232.238 204 348 133 227 151 180 79 145 351 93 188 139
2023/2024999 94 102 71 77 69 182 56 116 38 69 88 37
2024/20253.054 174 328 263 221 368 173 239 184 101 250 203 550
2025/20264.047 613 766 805 681 820 362 0 0 0 0 0 0
Totale 15.661